FLNA and PGK1 are Two Potential Markers for Progression in Hepatocellular Carcinoma

@article{Ai2011FLNAAP,
  title={FLNA and PGK1 are Two Potential Markers for Progression in Hepatocellular Carcinoma},
  author={Jianzhong Ai and H. Huang and X. Lv and Ziwei Tang and Mianzhi Chen and Tielin Chen and Weiwei Duan and Huan Sun and Qingwei Li and Ruizhi Tan and Yuhang Liu and J. Duan and Y. Yang and Yuquan Wei and Y. Li and Qin Zhou},
  journal={Cellular Physiology and Biochemistry},
  year={2011},
  volume={27},
  pages={207 - 216}
}
Background/Aims: Hepatocellular carcinoma (HCC) is one of the most deadly diseases; metastasis and recurrence are the most important factors that affect the therapy of HCC chronically. Until now, the prognosis for the metastasis of HCC had not improved. Recently, several proteins that are related to metastasis and invasion of HCC were identified, but the effective markers still remain to be elucidated. Methods: In this study, comparative proteomics was used to study the differentially expressed… Expand
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells.
Role and mechanism of FLNa and UCP2 in the development of cervical cancer
PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process
The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 48 REFERENCES
From Proteomic Analysis to Clinical Significance
PGK1 a Potential Marker for Peritoneal Dissemination in Gastric Cancer
Mechanism of Cancer Cell Adaptation to Metabolic Stress
Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients
...
1
2
3
4
5
...